WORK GROUP CO-CHAIRS
Adeera Levin, MD, FRCPC University of British Columbia Vancouver, Canada
Paul E Stevens, MB, FRCP East Kent Hospitals University NHS Foundation Trust Canterbury, United Kingdom
WORK GROUP
Rudy W Bilous, MD Newcastle University and James Cook University Hospital Middlesbrough, United Kingdom
Josef Coresh, MD, PhD, MHS Johns Hopkins University Baltimore, USA
Angel LM de Francisco, MD, PhD Hospital Universitario Valdecilla Santander, Spain
Paul E de Jong, MD, PhD University Medical Center Groningen Groningen, The Netherlands
Kathryn E Griffith, BM, BS, MSc, MRCP, MRCGP University Health Centre, York University York, United Kingdom
Brenda R Hemmelgarn, MD, PhD, FRCP(C) University of Calgary Alberta, Canada
Kunitoshi Iseki, MD University Hospital of the Ryukyus Nishihara, Okinawa, Japan
Edmund J Lamb, PhD, FRCPath East Kent Hospitals University NHS Foundation Trust Canterbury, United Kingdom
Andrew S Levey, MD Tufts Medical Center Boston, USA
Miguel C Riella, MD, PhD, FACP Evangelic University Hospital Curitiba, Brazil
Michael G Shlipak, MD, MPH VA Medical Center, UCSF San Francisco, USA
Haiyan Wang, MD Peking University First Hospital Beijing, China
Colin T White, MD, FRCPC University of British Columbia Vancouver, Canada
Christopher G Winearls, MB, DPhil, FRCP Oxford Radcliffe Hospitals NHS Trust Oxford, United Kingdom
EVIDENCE REVIEW TEAM
Tufts Center for Kidney Disease Guideline Development and Implementation
Tufts Medical Center, Boston, MA, USA:
Katrin Uhlig, MD, MS, Project Director; Director, Guideline Development
Dana Miskulin, MD, MS, Staff Nephrologist
Amy Earley, BS, Project Coordinator
Shana Haynes, MS, DHSc, Research Assistant
Jenny Lamont, MS, Project Manager
In addition, support and supervision were provided by:
Ethan M Balk, MD, MPH; Program Director, Evidence Based Medicine